DIAGNOS Inc. (DGNOF)
OTCMKTS · Delayed Price · Currency is USD
0.2300
0.00 (0.00%)
Feb 11, 2026, 10:25 AM EST
DIAGNOS Revenue
DIAGNOS had revenue of 15.16K CAD in the quarter ending September 30, 2025, a decrease of -33.14%. This brings the company's revenue in the last twelve months to 79.00K, down -48.53% year-over-year. In the fiscal year ending March 31, 2025, DIAGNOS had annual revenue of 103.80K, down -39.00%.
Revenue (ttm)
79.00K CAD
Revenue Growth
-48.53%
P/S Ratio
484.33
Revenue / Employee
3.59K CAD
Employees
22
Market Cap
27.47M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 103.80K | -66.36K | -39.00% |
| Mar 31, 2024 | 170.16K | -315.59K | -64.97% |
| Mar 31, 2023 | 485.75K | 46.92K | 10.69% |
| Mar 31, 2022 | 438.83K | 171.76K | 64.31% |
| Mar 31, 2021 | 267.07K | -64.44K | -19.44% |
| Mar 31, 2020 | 331.52K | 5.05K | 1.55% |
| Mar 31, 2019 | 326.47K | -1.29M | -79.76% |
| Mar 31, 2018 | 1.61M | -777.23K | -32.52% |
| Mar 31, 2017 | 2.39M | 1.41M | 143.51% |
| Mar 31, 2016 | 981.48K | 417.31K | 73.97% |
| Mar 31, 2015 | 564.18K | -2.14M | -79.14% |
| Mar 31, 2014 | 2.70M | 1.20M | 79.27% |
| Mar 31, 2013 | 1.51M | 181.09K | 13.64% |
| Mar 31, 2012 | 1.33M | 253.31K | 23.57% |
| Mar 31, 2011 | 1.07M | 716.44K | 200.08% |
| Mar 31, 2010 | 358.07K | -417.65K | -53.84% |
| Mar 31, 2007 | 775.72K | 66.53K | 9.38% |
| Mar 31, 2006 | 709.19K | 597.44K | 534.64% |
| Mar 31, 2005 | 111.75K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vaso Corporation | 89.11M |
| Veri Medtech Holdings | 11.89M |
| Pharma-Bio Serv | 9.00M |
| CareView Communications | 8.82M |
| DATATRAK International | 6.50M |
| BioRegenx | 1.93M |
| CompuMed | 1.69M |
DIAGNOS News
- 8 days ago - DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation - GlobeNewsWire
- 4 weeks ago - DIAGNOS Announces the Engagement of IBN - GlobeNewsWire
- 2 months ago - Diagnos Announces Closing of Oversubscribed $4 Million Brokered Private Placement Led by Centurion One Capital - GlobeNewsWire
- 3 months ago - DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on December 5, 2025 - GlobeNewsWire
- 3 months ago - DIAGNOS Announces $2.0 Million Brokered Private Placement Led by Centurion One Capital - GlobeNewsWire
- 4 months ago - DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on November 9, 2025 - GlobeNewsWire
- 4 months ago - DIAGNOS to Present at the Centurion One Capital 3rd Annual Bahamas Summit - Newsfile Corp
- 5 months ago - DIAGNOS Announces Voting Results of Meeting of Shareholders - GlobeNewsWire